Mitochondrial Dysfunction as a Therapeutic Target in Diabetic Cardiomyopathy: Progress and Prospects
Diabetic cardiomyopathy (DCM) is a specific type of cardiomyopathy that is independent of hypertension and coronary artery disease, and is closely associated with the high incidence and mortality of heart failure in people with diabetes. DCM causes microvascular disease, myocardial metabolic disorde...
Saved in:
| Main Authors: | Feng Zhang, Zhuqing Li, Yanxin Wang, Chao Li, Chengzhi Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2025-01-01
|
| Series: | Cardiovascular Innovations and Applications |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2024.0063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial dysfunction in diabetic ulcers: pathophysiological mechanisms and targeted therapeutic strategies
by: Yu Pan, et al.
Published: (2025-08-01) -
Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic Mice
by: Qing‐Bo Lu, et al.
Published: (2025-04-01) -
Atrial remodelling and dysfunction in hypertrophic cardiomyopathy: prognostic role and therapeutic target
by: Chiara Piazzai, et al.
Published: (2025-07-01) -
GPCRs identified on mitochondrial membranes: New therapeutic targets for diseases
by: Yanxin Pan, et al.
Published: (2025-07-01) -
Targeting ATF4-DDIT4/TXNIP induced mitochondrial dysfunction and ferroptosis: ISRIB as novel therapy for septic cardiomyopathy
by: Yiting Chen, et al.
Published: (2025-08-01)